Search earnings tickers

BMY

2025Q2BMO

Bristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-07-31 · Fiscal end 2025-06-30 · Features as of 2025-07-30

← Earnings history

Street

Consensus EPS1.10

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.0%

IV front—

P/C full—

P/C front—

Features as of2025-07-30

Run-up

Close—

Ret 5d-6.1%

Ret 10d-2.5%

Ret 20d-3.2%

Ret 30d-5.5%

Print

Actual EPS

1.46Beat

Estimated EPS1.10

Actual revenue

12.3B

Surprise %+32.7%

Beat / missBeat

Beat streak 44

Beat streak 85

Reaction

1-day stock reaction-1.9%

Implied vs actual

Implied 2.0%Actual 3.9%

Gap reaction-3.9%

Day result-5.8%

Next-day upNo

Realized / IV1.93×

Post tape

Post 5d+4.7%

Post 10d+10.4%

Post volume44.5M

Vol ×10d4.07×

Vol ×20d3.89×

Post range5.8%

BMY

Pre-Earnings Data